AI assistant
Roivant Sciences Ltd. — Director's Dealing 2024
Apr 27, 2024
30587_dirs_2024-04-26_54eeeb69-5f13-4de6-a262-727dd3499b75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2024-04-24
Reporting Person: MOMTAZEE JAMES C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-24 | Common Shares | A | 1490 | — | Acquired | 77829 | Direct |
| 2024-04-24 | Common Shares | F | 293 | $10.9 | Disposed | 77536 | Direct |
Footnotes
F1: Reflects an award of restricted stock covering Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
F2: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and the filing of this statement shall not be deemed an admission that the reporting person is, for purposes of Section 16 or otherwise, the beneficial owner of any of the reported securities.
F3: Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.